Nabi(美國)

Nabi Biopharmaceuticals

美國NabiBiopharmaceuticals www.nabi.com 美國Nabi生物制藥公司研發的一種用于治療尼古丁成癮和預防復吸疫苗NieVax（尼古丁接合疫苗）獲得FDA授予的快通道審批地位。該疫苗將在第二季度進入Ⅱ期概念驗證臨床試驗階段，包括300位患者，試驗結果將于2007年下半年得出。在未來幾年里，戒煙市場將發生明顯變化。PentaStaph（五金黃色葡萄球菌疫苗）Nab iBiopharmaceuticalsisfocusedondevelopingaseriesoffirstandsecondgenerationproductsthataddressunmetmedicalneedsandofferopportunitiesinourcorebusinessareas:nicotineaddictionandgram-positivebacterialinfections.Drivenbyourclinicaldevelopmentprograms,wearefocusedonbuildingvalueandareseekingpartnersforourvaccineprograms:NicVAX®(NicotineConjugateVaccine)andPentaStaph™(StaphylococcalPolysaccharideConjugateandToxoidVaccine).OurheadquartersislocatedinRockville,MarylandalongwithourResearchandDevelopmentfacility.